JUBLINGREA - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.2
Show all parameters (20 more)
🧾 Trade Setup
Buy Price: 628 ₹. Initial Stop Loss: 615 ₹ (protecting against immediate downside if volume weakens). Target Level 1: 645 ₹ – based on potential momentum from the brokerage radar inclusion. Target Level 2: 660 ₹ - with a successful break above 645, this could trigger further upside driven by high volume. Monitor closely; exit at 630₹ if the MACD doesn't show any signs of reversal or if volume stalls before reaching these targets.
✅ Positive
The stock is experiencing a significant quarter-over-quarter profit increase (114%) and has recently been highlighted in brokerage radars, suggesting potential upward momentum. Volume remains robust at over 11 million shares, indicating strong interest today.
⚠️ Limitation
Despite the positive profit growth, the extremely high P/E ratio of 28.7 relative to the industry’s PE of 29.3 means it is trading near the top end of its peer group and could be vulnerable if growth expectations aren't met. The MACD remains deeply negative, indicating a potential bearish trend, particularly with the significant price drop in Jubilant Ingrevia (as highlighted by recent news).
📉 Company Negative News
Recent news highlights that Jubilant Ingrevia reported a 32% YoY decline in net profit due to pricing pressures, creating headwinds for the broader sector.
📈 Company Positive News
The stock was recently identified as a top stock to watch by several brokerages, suggesting heightened interest and potential catalysts for movement today.
🏭 Industry
The pharmaceutical sector is currently experiencing mixed sentiment, driven by concerns over raw material costs and competitive pricing pressures (as indicated by Jubilant Ingrevia's results). However, broader market trends and overall sector valuations are relatively robust, with the industry PE aligning closely with the stock’s valuation.